Kenvue Inc.
KVUENYSE
Product information
What is Kenvue Inc. (KVUE)?
Kenvue Inc. is a consumer health company headquartered in Summit, New Jersey. It became independent in 2023 when Johnson & Johnson separated its consumer health business and listed it on the stock market. Its shares trade on the NYSE under the ticker KVUE. It is a constituent of the S&P 500 index.
Kenvue's brands fall into these groups: over-the-counter medicines such as Tylenol, Motrin and Nicorette; skin health and beauty products such as Neutrogena and Aveeno; and everyday health products such as Listerine, Johnson's and Band-Aid. The products are sold in pharmacies, supermarkets and online. The company has signed an acquisition agreement with Kimberly-Clark; stockholder approvals have been obtained and the transaction is expected to complete in the last quarter of 2026.
Those following Kenvue stock typically watch the completion timetable of the acquisition, regulatory approvals, product safety litigation and competition in the consumer health market. On the KVUE page at Lzzo.com, the share price is shown in US dollars together with a historical price chart and technical indicators.
Sources: kenvue.com, sec.gov, spglobal.com
- Name
- Kenvue Inc.
- Symbol
- KVUE
- Market
- Stocks
What to look for in the technical analysis of Kenvue Inc.
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…